Valente J F A, Pereira P, Sousa A, Queiroz J A, Sousa F
CICS-UBI-Health Sciences Research Centre, Universidade da Beira Interior, Avenida Infante D. Henrique, 6200-506 Covilhã, Portugal.
CDRsp-Centre Rapid and Sustainable Product Development, Polytechnic Institute of Leiria, 2411-901 Leiria, Portugal.
Polymers (Basel). 2021 Mar 5;13(5):793. doi: 10.3390/polym13050793.
Gene therapy could be simply defined as a strategy for the introduction of a functional copy of desired genes in patients, to correct some specific mutation and potentially treat the respective disorder. However, this straightforward definition hides very complex processes related to the design and preparation of the therapeutic genes, as well as the development of suitable gene delivery systems. Within non-viral vectors, polymeric nanocarriers have offered an ideal platform to be applied as gene delivery systems. Concerning this, the main goal of the study was to do a systematic evaluation on the formulation of pDNA delivery systems based on the complexation of different sized plasmids with chitosan (CH) or polyethyleneimine (PEI) polymers to search for the best option regarding encapsulation efficiency, surface charge, size, and delivery ability. The cytotoxicity and the transfection efficiency of these systems were accessed and, for the best p53 encoding pDNA nanosystems, the ability to promote protein expression was also evaluated. Overall, it was showed that CH polyplexes are more efficient on transfection when compared with the PEI polyplexes, resulting in higher P53 protein expression. Cells transfected with CH/p53-pDNA polyplexes presented an increase of around 54.2% on P53 expression, while the transfection with the PEI/p53-pDNA polyplexes resulted in a 32% increase.
基因治疗可以简单地定义为一种向患者引入所需基因的功能性拷贝的策略,以纠正某些特定突变并潜在地治疗相应疾病。然而,这个简单的定义掩盖了与治疗性基因的设计和制备以及合适的基因递送系统的开发相关的非常复杂的过程。在非病毒载体中,聚合物纳米载体提供了一个理想的平台来用作基因递送系统。关于此,该研究的主要目标是基于不同大小的质粒与壳聚糖(CH)或聚乙烯亚胺(PEI)聚合物的络合对pDNA递送系统的配方进行系统评估,以寻找关于包封效率、表面电荷、大小和递送能力的最佳选择。评估了这些系统的细胞毒性和转染效率,并且对于最佳的编码p53的pDNA纳米系统,还评估了其促进蛋白质表达的能力。总体而言,结果表明,与PEI多聚体相比,CH多聚体在转染方面更有效,导致更高的P53蛋白表达。用CH/p53-pDNA多聚体转染的细胞P53表达增加了约54.2%,而用PEI/p53-pDNA多聚体转染导致增加了32%。